Speaking at the JPMorgan Healthcare Conference, Roche Pharmaceuticals (RHHBY) CEO Teresa Graham talks about the firm’s focus on innovation and perspective with Yahoo Finance’s Anjalee Khemlani.
Graham states that Roche has “positioned itself as a company that embraces innovation” across various health care domains. At present, they recognize significant potential in the weight-loss medication sector as analysts predict the obesity market to reach $100 billion in the upcoming years. Nonetheless, Roche aspires to extend its application of creatinism beyond just obesity into neurological disorders.
Regarding partnerships, Graham mentions Roche seeks “pioneering science” that can “meaningfully alter the standard of care” for diseases with substantial unmet needs. She emphasizes their openness across therapeutic fields to support advancements that promote health.
#youtube #ROCHE #weightloss
About Yahoo Finance:
Yahoo Finance offers complimentary stock ticker data, current news, portfolio management tools, extensive market data, advanced resources, and additional information to assist you in managing your financial affairs.
– Get the latest news and data at finance.yahoo.com
– Download the Yahoo Finance app on Apple ( or Android (
– Follow Yahoo Finance on social:
X:
Instagram:
TikTok:
Facebook:
LinkedIn:
